1
/
of
0
FDA Drug Approval, N022496, EXPAREL
FDA Drug Approval, N022496, EXPAREL
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 022496
Company: PACIRA PHARMS INC
Drug Name: EXPAREL
Active Ingredients: BUPIVACAINE
Strength: 266MG/20ML (13.3MG/ML)
Dosage Form/Route: INJECTABLE, LIPOSOMAL;INJECTION
Action Date: 10/28/2011
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: PACIRA PHARMS INC
Drug Name: EXPAREL
Active Ingredients: BUPIVACAINE
Strength: 266MG/20ML (13.3MG/ML)
Dosage Form/Route: INJECTABLE, LIPOSOMAL;INJECTION
Action Date: 10/28/2011
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details